Diversified Trust Co decreased its position in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 15.1% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 56,129 shares of the company’s stock after selling 9,992 shares during the quarter. Diversified Trust Co’s holdings in Roche were worth $1,948,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of RHHBY. Wetzel Investment Advisors Inc. bought a new stake in shares of Roche in the 4th quarter worth about $53,000. HighPoint Advisor Group LLC bought a new stake in shares of Roche in the 4th quarter worth about $373,000. Associated Banc Corp increased its holdings in shares of Roche by 13.8% in the 4th quarter. Associated Banc Corp now owns 48,484 shares of the company’s stock worth $1,761,000 after buying an additional 5,890 shares during the last quarter. Hikari Power Ltd increased its holdings in shares of Roche by 0.8% in the 4th quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock worth $8,616,000 after buying an additional 2,000 shares during the last quarter. Finally, Bard Financial Services Inc. increased its holdings in shares of Roche by 36.6% in the 4th quarter. Bard Financial Services Inc. now owns 19,800 shares of the company’s stock worth $717,000 after buying an additional 5,300 shares during the last quarter.
Wall Street Analysts Forecast Growth
RHHBY has been the topic of several analyst reports. The Goldman Sachs Group initiated coverage on shares of Roche in a report on Thursday, May 30th. They set a “sell” rating on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th. Two analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. Based on data from MarketBeat, Roche currently has an average rating of “Hold” and an average price target of $40.00.
Roche Stock Up 0.7 %
Roche stock traded up $0.29 during trading hours on Wednesday, hitting $40.41. The company had a trading volume of 641,341 shares, compared to its average volume of 2,052,203. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.35 and a quick ratio of 1.04. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $41.15. The company has a 50-day moving average price of $36.68 and a two-hundred day moving average price of $33.61.
Roche Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
- Five stocks we like better than Roche
- When to Sell a Stock for Profit or Loss
- Microsoft Stock: Is Now The Time To Be Greedy?
- Retail Stocks Investing, Explained
- How to Invest in Mutual Funds
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Chipotle Mexican Grill: Take a Bite of This Smoking Hot Deal
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.